The SGC is engaged in dozens of collaborations with small companies to explore novel technologies

The SGC is engaged in dozens of collaborations with small companies to explore novel technologies.  In keeping with the SGC’s open-access policy,  all outputs from these collaboration are made publicly available without restriction on use.  As announced today, the SGC in Oxford is collaborating with C4X to discover chemical tools for epigenetic targets.  C4X will use its unique ligand conformation analysis technology to design potent inhibitors that will be tested at the SGC and rapidly made available to the public.